Brief: Lee's Pharmaceutical Holdings Sees FY Net Profit Attributable Of Between Hk$110 Mln & Hk$130 Mln
16/03/2020 12:15
March 16 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* EXPECTED TO RECORD AN UNAUDITED NET PROFIT ATTRIBUTABLE OF
BETWEEN HK$110 MILLION AND HK$130 MILLION FOR YEAR
* EXPECTED RESULT DUE TO NON-RECURRING LOSS OF ABOUT
HK$108.6
MILLION RECOGNISED IN FIRST HALF OF 2019
Source text for Eikon: urn:newsml:reuters.com:*:nHKSb9l4JZ
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA